NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services

Core Viewpoint - NetraMark Holdings Inc. has engaged LodeRock Advisors Inc. for strategic investor relations and capital markets communications to enhance its outreach and investor engagement efforts in the pharmaceutical industry [1][2]. Group 1: Investor Relations Strategy - The investor relations program will span 12 months and include a marketing schedule, investor targeting, analysis, outreach, and collaboration with investment dealers for non-deal roadshows [2]. - NetraMark will compensate LodeRock with a monthly fee of CAD $11,000 for these ongoing strategic communication services, starting from January 22, 2026 [3]. Group 2: Company Overview - NetraMark is focused on developing Generative Artificial Intelligence (Gen AI) and Machine Learning (ML) solutions specifically for the pharmaceutical sector, utilizing a unique topology-based algorithm to analyze patient data [6]. - The company's technology allows for the segmentation of diseases and classification of patients based on their sensitivity to drugs and treatment efficacy, enabling the use of smaller datasets for more accurate results [6].